913 related articles for article (PubMed ID: 20970847)
1. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.
Rothwell PM; Wilson M; Elwin CE; Norrving B; Algra A; Warlow CP; Meade TW
Lancet; 2010 Nov; 376(9754):1741-50. PubMed ID: 20970847
[TBL] [Abstract][Full Text] [Related]
2. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
Flossmann E; Rothwell PM;
Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602
[TBL] [Abstract][Full Text] [Related]
3. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.
Rothwell PM; Fowkes FG; Belch JF; Ogawa H; Warlow CP; Meade TW
Lancet; 2011 Jan; 377(9759):31-41. PubMed ID: 21144578
[TBL] [Abstract][Full Text] [Related]
4. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.
Rothwell PM; Wilson M; Price JF; Belch JF; Meade TW; Mehta Z
Lancet; 2012 Apr; 379(9826):1591-601. PubMed ID: 22440947
[TBL] [Abstract][Full Text] [Related]
5. Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.
Rothwell PM; Cook NR; Gaziano JM; Price JF; Belch JFF; Roncaglioni MC; Morimoto T; Mehta Z
Lancet; 2018 Aug; 392(10145):387-399. PubMed ID: 30017552
[TBL] [Abstract][Full Text] [Related]
6. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.
Rothwell PM; Price JF; Fowkes FG; Zanchetti A; Roncaglioni MC; Tognoni G; Lee R; Belch JF; Wilson M; Mehta Z; Meade TW
Lancet; 2012 Apr; 379(9826):1602-12. PubMed ID: 22440946
[TBL] [Abstract][Full Text] [Related]
7. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.
Miller EA; Pinsky PF; Schoen RE; Prorok PC; Church TR
Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):101-110. PubMed ID: 30502933
[TBL] [Abstract][Full Text] [Related]
8. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial.
Cook NR; Lee IM; Zhang SM; Moorthy MV; Buring JE
Ann Intern Med; 2013 Jul; 159(2):77-85. PubMed ID: 23856681
[TBL] [Abstract][Full Text] [Related]
9. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.
Algra AM; Rothwell PM
Lancet Oncol; 2012 May; 13(5):518-27. PubMed ID: 22440112
[TBL] [Abstract][Full Text] [Related]
10. Systematic review with meta-analysis: the comparative effectiveness of aspirin vs. screening for colorectal cancer prevention.
Emilsson L; Holme Ø; Bretthauer M; Cook NR; Buring JE; Løberg M; Adami HO; Sesso HD; Gaziano MJ; Kalager M
Aliment Pharmacol Ther; 2017 Jan; 45(2):193-204. PubMed ID: 27859394
[TBL] [Abstract][Full Text] [Related]
11. Low-dose aspirin and incidence of colorectal tumors in a randomized trial.
Gann PH; Manson JE; Glynn RJ; Buring JE; Hennekens CH
J Natl Cancer Inst; 1993 Aug; 85(15):1220-4. PubMed ID: 8331682
[TBL] [Abstract][Full Text] [Related]
12. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial.
Atkin W; Wooldrage K; Parkin DM; Kralj-Hans I; MacRae E; Shah U; Duffy S; Cross AJ
Lancet; 2017 Apr; 389(10076):1299-1311. PubMed ID: 28236467
[TBL] [Abstract][Full Text] [Related]
13. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.
Ruder EH; Laiyemo AO; Graubard BI; Hollenbeck AR; Schatzkin A; Cross AJ
Am J Gastroenterol; 2011 Jul; 106(7):1340-50. PubMed ID: 21407185
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials.
Holme Ø; Schoen RE; Senore C; Segnan N; Hoff G; Løberg M; Bretthauer M; Adami HO; Kalager M
BMJ; 2017 Jan; 356():i6673. PubMed ID: 28087510
[TBL] [Abstract][Full Text] [Related]
15. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies.
Brenner H; Stock C; Hoffmeister M
BMJ; 2014 Apr; 348():g2467. PubMed ID: 24922745
[TBL] [Abstract][Full Text] [Related]
16. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.
Hassan C; Rex DK; Cooper GS; Zullo A; Launois R; Benamouzig R
Gut; 2012 Aug; 61(8):1172-9. PubMed ID: 21997545
[TBL] [Abstract][Full Text] [Related]
17. Aspirin Use on Incidence and Mortality of Gastrointestinal Cancers: Current State of Epidemiological Evidence.
Huang WK; Tu HT; See LC
Curr Pharm Des; 2015; 21(35):5108-15. PubMed ID: 26369680
[TBL] [Abstract][Full Text] [Related]
18. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Guirguis-Blake JM; Evans CV; Perdue LA; Bean SI; Senger CA
JAMA; 2022 Apr; 327(16):1585-1597. PubMed ID: 35471507
[TBL] [Abstract][Full Text] [Related]
19. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force.
Chubak J; Whitlock EP; Williams SB; Kamineni A; Burda BU; Buist DS; Anderson ML
Ann Intern Med; 2016 Jun; 164(12):814-25. PubMed ID: 27064482
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
